Skip to main content

梅毒テスト市場：将来の予測は印象的な成長率を示しています

 


Rising Syphilis cases remain a vital public health issue and is a significant concern across the globe, especially in developing economies. Rising burden of syphilis incidences and implementation of national screening programs are major factors fuelling the growth of Syphilis testing worldwide. Furthermore, the growing adoption of novel technologies such as Enzyme Immunoassay (EIA) tests, Darkfield microscopy and Microhemagglutination (MHA-TP) assay enables faster and improved screening results - thus provides additional boost to the market growth. However, social stigma associated with patients visiting to STD clinics and large patient pool in remote areas would limit the market growth to a certain extent.

The global syphilis testing market is expected to garner $3,650.3 million by 2020, registering a CAGR of 1.2% during the period 2014-2020. The secondary syphilis testing would continue to be the largest market segment through 2020.Latin America, Middle East & Africa (LAMEA) market accounted for about 43% revenue share of the syphilis testing market in 2014.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/675

LAMEA and Asia Pacificconstitute the two largest regions for syphilis testing market and collectively accounted for about 4/5th of the global revenue in 2014. Higher adoption rates for technologically advanced screening tests methods, active measures from governments and private associations along with the growing awareness of syphilis infections, largely contributes to the growth of the market in these regions. Also, rising incidences of syphilis due to men having sex with men (MSM) and implementation of mandatory screening tests for all pregnant women would further foster the growth of syphilis testing market in these regions.

The Major Key Players Are:

·        Roche Diagnostics

·        Hologic, Inc.

·        Becton Dickinson & Company

·        Abbott Laboratories

·        BioMerieux

·        Alere Inc.

·        Cepheid Inc.

·        Affymetrix, Inc.

·        Diasorin.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/675

Key findings of Syphilis Testing Market:

  • LAMEA will continue to lead the global market, closely followed by Asia Pacific, all through the analysis period
  • United states remains a major market in the North Americasyphilis testing market through 2020
  • Spainand Germanycollectively accounts for about one fourth of the Europesyphilis testing market
  • ChinaandIndiacollectively accounts for about 89% share in theAsia Pacificsyphilis testing market

Access Full Report @ https://www.alliedmarketresearch.com/syphilis-testing-market

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Labels:

Comments

Post a Comment

Popular posts from this blog

核医学市場は世界的なビジネス予測2030年に急成長しています

  The global radiopharmaceuticals market is poised to grow at a significant pace, owing to growing demand for non-invasive techniques, availability of effective cancer treatment, and ability to observe the functioning of the organ from outside the body. Furthermore, increasing incidence of cancer & cardiovascular aliments, growing demand for alpha radio immunotherapy-based targeted cancer treatment, mounting call for nuclear imaging techniques, and advancements in radiotracers are expected to open new avenues in the radiopharmaceuticals market. Factors that are expected to drive the use of radiopharmaceuticals include changing lifestyle, elevated levels of stress, and ability to identify various diseases sooner than other diagnostic tests. However, factors such as supply volatility & logistical challenges, stringent regulatory vigil, and competition from conventional diagnostic procedures are anticipated to impede the market growth. T he global radiopharmaceuticals market i...
Post a Comment
Read more

外科ナビゲーションシステム市場 Expected to Reach $963 Million by 2022

Surgical navigation systems market was valued at   $628 million   in 2015, and is projected to reach   $963 million   by 2022, growing at a CAGR of 6.3% from 2016 to 2022, according to a new report published by Allied Market Research. Optical navigation systems segment is expected to grow at the highest growth rate during the forecast period, owing to benefits such as minimum radiation exposure and preciseness & accuracy during complex surgeries. The major factors that drive the growth of this market include rise in adoption of minimal invasive surgeries, improvement in healthcare infrastructure in emerging economies, numerous technological advancements, increase in incidence of ENT and neurosurgery-related disorders, and growth in knee replacement surgeries globally. However, high cost of these systems and stringent FDA rules are the major barriers that restrain the market growth. Get access to detailed report at:   https://www.alliedmarketresearch.com/sur...
Post a Comment
Read more

抗真菌薬市場 to Reach $17.72 Billion by 2023 at 3.7% CAGR

According to the report, the global Antifungal Drugs market generated $14.23 billion in 2017 and is estimated to reach $17.72 billion by 2023, growing at a CAGR of 3.7% from 2017 to 2023. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario. Favorable government funds to combat the antifungal diseases along with the increasing prevalence of fungal infection drive the growth of the market. Furthermore, rising awareness levels pertaining to myriad fungal infections supplement the market growth. However, the growing population with antifungal drug resistance and the presence of counterfeit drugs and side effects of antifungal drugs restrict the growth. On the other hand, patent expirations and increasing funding from public & private organizations offer lucrative opportunities for the market. Request Report Sample at:  https://www.alliedmarketresearch.com/request-sample/2370 B...
Post a Comment
Read more